Related Experiment Video
Updated: Jun 25, 2026
14:42
Isolation and Analysis of Hematopoietic Stem Cells from the Placenta
Published on: June 24, 2008
[Sickle cell anemia in perinatal placental diagnostics]
1Institut für Pathologie und Zytologie, Dr. Horst Schmidt-Klinken, Wiesbaden, Deutschland. moppitz@anatom.uni-tuebingen.de
Der Pathologe
|March 3, 2009
Summary
Hereditary hemoglobinopathies can alter placental pathology, impacting fetal development. Recognizing these conditions is crucial for diagnosing fetal growth issues and spontaneous abortions.
Area of Science:
- Obstetrics and Gynecology
- Pathology
- Genetics
Background:
- Hereditary hemoglobinopathies are genetic disorders affecting hemoglobin production.
- These conditions can manifest with placental abnormalities and impact fetal outcomes.
- Differential diagnosis in placental pathology requires consideration of hemoglobinopathies.
Observation:
- Placental examination for fetal growth retardation and spontaneous abortion should include hemoglobinopathies in the differential diagnosis.
- Hemoglobinopathies induce macroscopic and microscopic placental changes detectable during routine pathology.
- A case illustrating heterozygous and homozygous genotypes highlights diagnostic and therapeutic planning.
Findings:
- Hemoglobinopathies significantly influence placental pathology, presenting diverse macroscopic and microscopic alterations.
- The severity of placental changes correlates with the genotype (heterozygous vs. homozygous).
- These placental changes are relevant for routine pathology and interdisciplinary diagnostics.
Implications:
- Integrating hemoglobinopathy screening into placental pathology improves diagnostic accuracy for fetal growth issues.
- Interdisciplinary collaboration between obstetrics and pathology is vital for optimal patient management.
- Understanding hemoglobinopathy's placental effects aids in predicting and managing fetal development complications.